Home  |  About Us  |  Login  |  Contact Us

   
 
 
 
 
 
         
   


Free NewsLetter
Receive email alerts of new market research reports in your industry.
Sign Up Today >>
Special Offers
In this section, latest discounts and offers are available for purchase.
Click Here >>
RSS Feeds
Get updated new offer RSS feeds of new products.
Access RSS Feeds today >>
Latest News
Receive email alerts of new market research latest news in your industry.
View All News >>
Share This
Bookmark and Share
 


 
Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, 2011
Product ID : VSI-9999-75
Published Date : Mar 2011
Pages : 46

 

Overview:

Summary

Clinical trial report, “Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, 2011"" provides data on the Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Aneurysmal Subarachnoid Hemorrhage (SAH). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Aneurysmal Subarachnoid Hemorrhage (SAH). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies


Table Of Contents :

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Aneurysmal Subarachnoid Hemorrhage (SAH) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Aneurysmal Subarachnoid Hemorrhage (SAH) 20
Subjects Recruited Over a Period of Time 21
Prominent Sponsors 22
Top Companies Participating in Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials 24
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Actelion Ltd 26
Clinical Trial Overview of Actelion Ltd 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
National Taiwan University Hospital 27
Clinical Trial Overview of National Taiwan University Hospital 27
University of Cambridge 28
Clinical Trial Overview of University of Cambridge 28
University of Illinois 29
Clinical Trial Overview of University of Illinois 29
Oslo University Hospital Health 30
Clinical Trial Overview of Oslo University Hospital Health 30
University Hospital Mannheim 31
Clinical Trial Overview of University Hospital Mannheim 31
Soroka University Medical Center 32
Clinical Trial Overview of Soroka University Medical Center 32
Centre hospitalier de l'Universite de Montreal (CHUM) 33
Clinical Trial Overview of Centre hospitalier de l'Universite de Montreal (CHUM) 33
University of Virginia 34
Clinical Trial Overview of University of Virginia 34
University of California, Los Angeles 35
Clinical Trial Overview of University of California, Los Angeles 35
Rouen University Hospital 36
Clinical Trial Overview of Rouen University Hospital 36
Rigshospitalet 37
Clinical Trial Overview of Rigshospitalet 37
University of Miami 38
Clinical Trial Overview of University of Miami 38
Vanderbilt University 39
Clinical Trial Overview of Vanderbilt University 39
University of Illinois 40
Clinical Trial Overview of University of Illinois 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Charite University 42
Clinical Trial Overview of Charite University 42
Appendix 43
Abbreviations 43
Definitions 43
Research Methodology 44
Secondary Research 44
About GlobalData 45
Contact Us 45
Disclaimer 45
Source 45

List of Tables
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 11
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries, 2011* 15
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, BRIC Countries, 2011* 16
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Phase, 2011* 17
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 18
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Terminated Clinical Trials, 2011* 20
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 23
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 24
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 25
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2011* 26
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011* 27
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cambridge, 2011* 28
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2011* 29
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital Health, 2011* 30
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Mannheim, 2011* 31
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Soroka University Medical Center, 2011* 32
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre hospitalier de l'Universite de Montreal (CHUM), 2011* 33
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2011* 34
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2011* 35
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2011* 36
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2011* 37
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2011* 38
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2011* 39
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2011* 40
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011* 41
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2011* 42

List of Figures
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011* 15
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, BRIC Countries (%), 2011* 16
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 17
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 18
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 25
GlobalData Methodology 44


Publisher : GlobalData